FDA Approves Injectable Drug To Treat Opioid-Dependent Patients
Links shared publicly online about this topic.
- 804total visits
FDA Approves Injectable Drug To Treat Opioid-Dependent Patients
View full resource at medicalnewstoday.com
Tags: Pain, Addiction, Substance Addiction, Drug, FDA
Most Recently Shared on October 15, 2010 at 3:05 pm By:
FDA Approves Injectable Drug To Treat Opioid-Dependent Patients http://mnt.to/3L8Z #pain
Also Shared By:
Affymax and Takeda Announce FDA Approval of Omontys (peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis
drugs.com — “Omontys (peginesatide) is used to treat anemia due to Chronic Kidney Disease. Includes Omontys side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 27, 2012 at 11:06 pm By:
Drugs and Devices OW OW Health
Affymax and Takeda Announce FDA Approval of Omontys (peginesatide) Injection for the Treatment of Anemia D... http://t.co/O4BqcAm5 #drug
Medical News: FDA Approves Icatibant for Rare Swelling Condition - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the injectable drug icatibant (Firazyr) to treat acute hereditary angioedema (HAE) attacks, making it the first such medication available in the U.S. that patients w” View full resource at medpagetoday.com
Most Recently Shared on August 30, 2011 at 9:04 pm By:
Roger D. Jones, PhD Health Social Media, PhD, Doctor, and Health Executive
Medical News: FDA Approves Icatibant for Rare Swelling Condition - http://t.co/NEqppzp from @medpagetoday #health #medicine
Medical News: FDA Approves Icatibant for Rare Swelling Condition - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the injectable drug icatibant (Firazyr) to treat acute hereditary angioedema (HAE) attacks, making it the first such medication available in the U.S. that patients w” View full resource at medpagetoday.com
Most Recently Shared on August 25, 2011 at 4:48 pm By:
FDA approves Firazyr for hereditary angioedema attacks http://t.co/NOnqDXA
FDA Approves Injectable Gel To Treat Fecal Incontinence
medicalnewstoday.com — “The U.S. Food and Drug Administration approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medica” View full resource at medicalnewstoday.com
Most Recently Shared on May 28, 2011 at 7:05 am By:
MNT Drug Approvals Health News
FDA Approves Injectable Gel To Treat Fecal Incontinence http://mnt.to/3WtJ #regulatory
FDA Approves Botox To Treat Chronic Migraine - QualityPoint Technologies
qualitypointtech.net — “The U.S. Food and Drug Administration approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine is defined as having a history of migraine and experiencing a headache on most days of the month.” View full resource at qualitypointtech.net
Most Recently Shared on October 16, 2010 at 9:49 pm By:
FDA Approves Botox To Treat Chronic Migraine: The U.S. Food and Drug Administration approved Botox injection (onab... http://bit.ly/ashS1P
FDA Approves Botox To Treat Chronic Migraine
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine is defined as having a history of” View full resource at medicalnewstoday.com
Most Recently Shared on October 16, 2010 at 1:05 pm By:
FDA Approves Botox To Treat Chronic Migraine http://mnt.to/3Lkq #headache #migraine
FDA approves Botox to treat chronic migraine
fda.gov — “The U.S. Food and Drug Administration today approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine is defined as having a history of migraine and experiencing a headache on most days of the month.” View full resource at fda.gov
Most Recently Shared on October 15, 2010 at 9:47 pm By:
FDA approves Botox 2 prevent headaches in people w/ chronic migraine disorder, characterized by almost daily migraines http://bit.ly/bNB8u5
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA - QualityPoint Technologies
qualitypointtech.net — “Vivitrol (Naltrexone) in injection form has been approved by the FDA (Food and Drug Administration) for opioid dependent patients - individuals addicted to opioids - who have received detoxification therapy. The injection is administered into the muscle (intramuscularly) once per month. Naltrexone is an opioid receptor antagonist - it blocks the brain's opioid receptors. Examples of opioids include heroin, morphine, codeine, and thebaine...” View full resource at qualitypointtech.net
Most Recently Shared on October 15, 2010 at 9:49 am By:
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA: Vivitrol (Naltrexone) in injection... http://bit.ly/aspHvY
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA
medicalnewstoday.com — “Vivitrol (Naltrexone) in injection form has been approved by the FDA (Food and Drug Administration) for opioid dependent patients - individuals addicted to opioids - who have received detoxificati” View full resource at medicalnewstoday.com
Most Recently Shared on October 14, 2010 at 9:26 pm By:
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA Vivitrol (Naltrexone) in injection form .. http://dld.bz/z9S8
FDA Approves Vivitrol to Treat Opioid-dependent Patients
drugs.com — “Vivitrol (naltrexone) is used to treat alcohol dependence and opioid dependence. Includes Vivitrol side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 13, 2010 at 11:08 pm By:
Drugs and Devices OW OW Health
FDA Approves Vivitrol to Treat Opioid-dependent Patients: ROCKVILLE, Md., Oct. 12, 2010--The U.S. Food and Dr... http://bit.ly/98nTjo #drug
Vivitrol approved for opioid dependence - MPR
empr.com — “The FDA has approved Vivitrol (naltrexone for injection, from Alkermes) to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.” View full resource at empr.com
Most Recently Shared on October 13, 2010 at 3:43 pm By:
MPR News: Vivitrol approved for opioid dependence: The FDA has approved Vivitrol (naltrexone extended-release inje... http://bit.ly/9cWdEE
FDA Approves First Pill For Multiple Sclerosis
rttnews.com — “Multiple sclerosis patients on injectable drugs in the U.S. have been wishing to replace their shots with oral drugs for a long time. The FDA-approved drugs used to treat multiple sclerosis thus far involve injections or intravenous infusions.” View full resource at rttnews.com
Most Recently Shared on September 22, 2010 at 10:27 pm By:
George Jelinek Emergency Physician, Physician, and Doctor
FDA approves oral fingolimod for MS http://www.rttnews.com/Content/TopStories.aspx?Id=1425426
FDA Approves First Pill For Multiple Sclerosis
rttnews.com — “Multiple sclerosis patients on injectable drugs in the U.S. have been wishing to replace their shots with oral drugs for a long time. The FDA-approved drugs used to treat multiple sclerosis thus far involve injections or intravenous infusions.” View full resource at rttnews.com
Most Recently Shared on September 22, 2010 at 2:06 pm By:
FDA Approves First Pill For Multiple Sclerosis: Multiple sclerosis patients on injectable drugs in the U.S. have b... http://bit.ly/8XN9xB
Eisai's Dacogen five-day dosing regimen for treatment of MDS receives FDA approval
news-medical.net — “Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.” View full resource at news-medical.net
Most Recently Shared on March 12, 2010 at 7:38 am By:
News-Medical.Net Oncology and Health News
Oncology News: Eisai's Dacogen five-day dosing regimen for treatment of MDS receives FDA approval: Eisai Inc. tod... http://bit.ly/a0PEds
Advertisement
MNT Alcohol / Addict
@mnt_alcoholadd
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA http://mnt.to/3LfM #alcohol #addiction
1 year ago...